Philippines - Antisera And Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingAntisera Price in the Philippines - 2023
Contents:
- Antisera Price in the Philippines (CIF) - 2022
- Antisera Price in the Philippines (FOB) - 2022
- Antisera Imports in the Philippines
- Antisera Exports in the Philippines
Antisera Price in the Philippines (CIF) - 2022
The average antisera import price stood at $67,001 per ton in 2022, surging by 7.2% against the previous year. In general, the import price, however, continues to indicate a pronounced curtailment. The pace of growth was the most pronounced in 2021 when the average import price increased by 24% against the previous year. The import price peaked at $101,903 per ton in 2012; however, from 2013 to 2022, import prices stood at a somewhat lower figure.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Germany ($230,179 per ton), while the price for China ($26,547 per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+5.1%), while the prices for the other major suppliers experienced more modest paces of growth.
Antisera Price in the Philippines (FOB) - 2022
In 2022, the average antisera export price amounted to $36,910 per ton, with a decrease of -44.2% against the previous year. Overall, the export price continues to indicate a abrupt downturn. The pace of growth appeared the most rapid in 2020 when the average export price increased by 445%. As a result, the export price attained the peak level of $595,314 per ton. From 2021 to 2022, the average export prices remained at a lower figure.
Average prices varied somewhat for the major external markets. In 2022, amid the top suppliers, the country with the highest price was Hong Kong SAR ($44,000 per ton), while the average price for exports to Singapore stood at $34,371 per ton.
From 2014 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Spain (+20.6%), while the prices for the other major destinations experienced a decline.
Antisera Imports in the Philippines
In 2022, after three years of growth, there was decline in purchases abroad of antisera and other blood fractions, when their volume decreased by -1.4% to 1.9K tons. In general, imports, however, posted significant growth. The pace of growth was the most pronounced in 2020 when imports increased by 103%.
In value terms, antisera imports expanded significantly to $131M in 2022. Overall, imports, however, enjoyed a significant increase. The pace of growth was the most pronounced in 2020 with an increase of 74% against the previous year. Over the period under review, imports reached the peak figure in 2022 and are expected to retain growth in the near future.
| Import of Antisera in the Philippines (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Germany | 9.2 | 20.8 | 29.7 | 28.0 | 44.9% |
| United States | 10.1 | 13.1 | 17.0 | 24.3 | 34.0% |
| India | 4.2 | 9.6 | 10.0 | 15.1 | 53.2% |
| South Korea | 9.1 | 10.0 | 13.1 | 14.8 | 17.6% |
| Ireland | 4.3 | 7.2 | 9.4 | 9.7 | 31.1% |
| Switzerland | 4.9 | 7.6 | 11.3 | 8.2 | 18.7% |
| China | 2.3 | 8.0 | 6.1 | 6.5 | 41.4% |
| France | 4.9 | 9.1 | 13.2 | 6.2 | 8.2% |
| Singapore | 1.1 | 1.0 | 1.9 | 5.5 | 71.0% |
| Japan | 0.3 | 2.9 | 6.1 | 1.5 | 71.0% |
| Others | 3.5 | 4.3 | 5.6 | 10.8 | 45.6% |
| Total | 53.9 | 93.5 | 124 | 131 | 34.5% |
Top Suppliers of Antisera to the Philippines in 2022:
- United States (623.6 tons)
- China (244.6 tons)
- France (208.9 tons)
- Ireland (175.8 tons)
- India (135.6 tons)
- Singapore (127.6 tons)
- Germany (121.5 tons)
- South Korea (79.1 tons)
- Japan (59.4 tons)
- Switzerland (49.9 tons)
Antisera Exports in the Philippines
In 2022, antisera exports from the Philippines declined rapidly to 289 kg, dropping by -24.3% compared with the previous year. Over the period under review, exports, however, posted a significant expansion. The pace of growth appeared the most rapid in 2021 with an increase of 216% against the previous year. As a result, the exports attained the peak of 382 kg, and then shrank rapidly in the following year.
In value terms, antisera exports shrank sharply to $11K in 2022. Overall, exports showed a deep contraction. The pace of growth was the most pronounced in 2020 with an increase of 310%. As a result, the exports attained the peak of $72K. From 2021 to 2022, the growth of the exports failed to regain momentum.
| Export of Antisera in the Philippines (Thousand USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Singapore | 3.2 | 2.1 | N/A | 9.8 | 45.2% |
| Hong Kong SAR | N/A | 0.6 | 0.7 | 0.1 | -59.2% |
| Spain | N/A | 12.8 | 7.3 | N/A | -43.0% |
| Japan | 4.6 | 0.1 | 0.1 | N/A | -85.3% |
| Vietnam | N/A | N/A | 0.1 | N/A | 0% |
| Malaysia | 5.3 | N/A | N/A | N/A | 0% |
| United States | 0.4 | 0.1 | 0.1 | N/A | -50.0% |
| Papua New Guinea | N/A | N/A | 0.4 | N/A | 0% |
| India | N/A | 0.2 | N/A | N/A | 0% |
| Oman | N/A | N/A | 12.9 | N/A | 0% |
| Australia | N/A | N/A | 3.3 | N/A | 0% |
| Others | 4.1 | 56.1 | 0.2 | 0.7 | -44.5% |
| Total | 17.6 | 72.0 | 25.3 | 10.7 | -15.3% |
Top Export Markets for Antisera from the Philippines in 2022:
- Singapore (286.0 kg)
- Hong Kong SAR (2.0 kg)
This report provides an in-depth analysis of the antisera market in the Philippines. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202125 - Antisera, other immunological products which are directly involved in the regulation of immunological processes and other blood fractions
Country coverage:
- Philippines
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in the Philippines
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
578
This report provides an in-depth analysis of the antisera market in the Philippines.
417
This report provides an in-depth analysis of the biological product market in the Philippines.
574
This report provides an in-depth analysis of the vaccine market in the Philippines.
339
This report provides an in-depth analysis of the market for human and animal blood in the Philippines.
680
This report provides an in-depth analysis of the veterinary medicine vaccines market in the Philippines.
2287
This report provides an in-depth analysis of the global antisera market.
560
This report provides an in-depth analysis of the global biological product market.
2848
This report provides an in-depth analysis of the global vaccine market.
647
This report provides an in-depth analysis of the global market for human and animal blood.
754
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
275
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
1156
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
1077
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
1258
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
1266
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
3235
From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to X million USD in 2015. There was an annual increase of +X% throughout the analyzed period.
503
Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported X thousand tons of antisera and other blood fractions totaling X billion USD, X% over the previous year. Its primary trading partner was G
239
Explore the top import markets for Biological Products worldwide, including the United States, Germany, Belgium, and more. Discover key statistics and import values in this article.
595
Due to widespread Covid vaccination rates, the global trade in vaccines reached $42.5B, the highest level ever. Belgium topped the country rankings by the value of exports this year, followed by Germany and the U.S. Growing global demand stimulates the rapid expansion of Covid vaccine production facilities in the EU.
1231
Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported X tons of vaccines for human medicine totaling $X, X% over the previous year. Its primary trading partner was France, where it supplied X% o
